000877918 001__ 877918
000877918 005__ 20220930130245.0
000877918 0247_ $$2doi$$a10.1089/adt.2020.991
000877918 0247_ $$2ISSN$$a1540-658X
000877918 0247_ $$2ISSN$$a1557-8127
000877918 0247_ $$2Handle$$a2128/26309
000877918 0247_ $$2pmid$$apmid:32749852
000877918 0247_ $$2WOS$$aWOS:000556911700001
000877918 037__ $$aFZJ-2020-02510
000877918 041__ $$aEnglish
000877918 082__ $$a540
000877918 1001_ $$0P:(DE-Juel1)131810$$aBier, Dirk$$b0$$eCorresponding author$$ufzj
000877918 245__ $$aDevelopment and Evaluation of a Versatile Receptor-Ligand Binding Assay Using Cell Membrane Preparations Embedded in an Agarose Gel Matrix and Evaluation with the Human Adenosine A1 Receptor
000877918 260__ $$aLarchmont, NY$$bLiebert$$c2020
000877918 3367_ $$2DRIVER$$aarticle
000877918 3367_ $$2DataCite$$aOutput Types/Journal article
000877918 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1606470699_10660
000877918 3367_ $$2BibTeX$$aARTICLE
000877918 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000877918 3367_ $$00$$2EndNote$$aJournal Article
000877918 520__ $$aGuanosine-5′-triphosphate (GTP)-binding protein-coupled receptors are the target of up to 40% of prescribed medications worldwide. To evaluate the suitability of novel receptor ligands, frequently elaborate, time-consuming, and expensive receptor-ligand interaction studies have to be carried out. This work describes the development and proof of principle of a rapid, sensitive, and reliable receptor-ligand binding assay. CHO cells were stably transfected with a construct encoding the human A1 adenosine receptor (hA1AR). For ligand binding assays, membranes from these cells were prepared and embedded in low melting point agarose. These “immobilized” samples were incubated with tritiated 8-cyclopentyl-1,3-dipropylxanthine ([3H]DPCPX), a well-established receptor antagonist. The KD and Bmax values as well as kinetic parameters (kon and koff) of receptor-ligand interaction were determined. Unspecific binding of various radiotracers to either the carrier material or the agarose gel matrix was negligible. The dissociation constant (KD) for [3H]DPCPX at the hA1AR was determined by saturation, competition binding, and kinetic experiments. These studies resulted in KD values of ∼3 nM, which is in good accordance with previously published data obtained from conventional receptor-ligand binding assays. The procedure described in this study simplifies classical binding studies to a kit-like assay. The receptors retained their binding properties even when preparations were dried completely. Transport and delivery of the material are conceivable without loss of biological activity. Therefore, other laboratories can perform binding studies without special equipment or the necessity to run a cell culture laboratory and/or to dissect tissue on their own.
000877918 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000877918 588__ $$aDataset connected to CrossRef
000877918 7001_ $$0P:(DE-Juel1)131847$$aSchulze, Annette$$b1$$ufzj
000877918 7001_ $$0P:(DE-Juel1)131824$$aHolschbach, Marcus$$b2$$ufzj
000877918 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b3$$ufzj
000877918 7001_ $$0P:(DE-Juel1)131911$$aBaumann, A.$$b4$$ufzj
000877918 773__ $$0PERI:(DE-600)2099740-1$$a10.1089/adt.2020.991$$gp. adt.2020.991$$n7$$p  $$tAssay and drug development technologies$$v18$$x1540-658X$$y2020
000877918 8564_ $$uhttps://juser.fz-juelich.de/record/877918/files/Invoice_065890.pdf
000877918 8564_ $$uhttps://juser.fz-juelich.de/record/877918/files/Development%20and%20evaluation%20of%20a%20versatile%20receptor-ligand%20binding%20assay%20.pdf$$yPublished on 2020-10-12. Available in OpenAccess from 2021-10-12.
000877918 8564_ $$uhttps://juser.fz-juelich.de/record/877918/files/Development%20and%20evaluation%20of%20a%20versatile%20receptor-ligand%20binding%20assay%20.pdf?subformat=pdfa$$xpdfa$$yPublished on 2020-10-12. Available in OpenAccess from 2021-10-12.
000877918 8767_ $$8065890$$92020-07-23$$d2020-08-19$$eColour charges$$jZahlung erfolgt$$pADT-2020-991.R1$$zBei Verzögerung Clemens 5747 anrufen,USD 600,-, Belegnr. 1200156648
000877918 909CO $$ooai:juser.fz-juelich.de:877918$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000877918 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131810$$aForschungszentrum Jülich$$b0$$kFZJ
000877918 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131847$$aForschungszentrum Jülich$$b1$$kFZJ
000877918 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131824$$aForschungszentrum Jülich$$b2$$kFZJ
000877918 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b3$$kFZJ
000877918 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131911$$aForschungszentrum Jülich$$b4$$kFZJ
000877918 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000877918 9141_ $$y2020
000877918 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000877918 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bASSAY DRUG DEV TECHN : 2018$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-17
000877918 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-01-17$$wger
000877918 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-17
000877918 920__ $$lyes
000877918 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000877918 9201_ $$0I:(DE-Juel1)IBI-1-20200312$$kIBI-1$$lMolekular- und Zellphysiologie$$x1
000877918 980__ $$ajournal
000877918 980__ $$aVDB
000877918 980__ $$aUNRESTRICTED
000877918 980__ $$aI:(DE-Juel1)INM-5-20090406
000877918 980__ $$aI:(DE-Juel1)IBI-1-20200312
000877918 980__ $$aAPC
000877918 9801_ $$aAPC
000877918 9801_ $$aFullTexts